Free Trial

Evolus (EOLS) Short Interest Ratio & Short Volume

Evolus logo
$9.21 -0.44 (-4.52%)
As of 10:14 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Evolus Short Interest Data

Evolus (EOLS) has a short interest of 12.00 million shares, representing 19.78% of the float (the number of shares available for trading by the public). This marks a 13.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.3, indicating that it would take 11.3 days of the average trading volume of 930,298 shares to cover all short positions.

Current Short Interest
12,000,000 shares
Previous Short Interest
10,610,000 shares
Change Vs. Previous Month
+13.10%
Dollar Volume Sold Short
$110.52 million
Short Interest Ratio
11.3 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
64,476,000 shares
Short Percent of Float
19.78%
Today's Trading Volume
78,584 shares
Average Trading Volume
930,298 shares
Today's Volume Vs. Average
8%
Short Selling Evolus?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Evolus and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EOLS Short Interest Over Time

EOLS Days to Cover Over Time

EOLS Percentage of Float Shorted Over Time

Evolus Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202512,000,000 shares $110.52 million +13.1%19.8%11.3 $9.21
6/15/202510,610,000 shares $105.36 million +9.7%17.5%10.1 $9.93
5/31/20259,670,000 shares $90.61 million +4.7%16.3%9.7 $9.37
5/15/20259,240,000 shares $92.40 million +5.7%15.5%10.3 $10.00
4/30/20258,740,000 shares $99.64 million +14.0%N/A10 $11.40
4/15/20257,670,000 shares $78.46 million +7.3%12.9%9.1 $10.23
3/31/20257,150,000 shares $86.01 million +1.4%12.0%8.5 $12.03
3/15/20257,050,000 shares $93.06 million +3.5%11.9%9 $13.20
2/28/20256,810,000 shares $99.36 million +3.8%11.5%9 $14.59
2/15/20256,560,000 shares $96.69 million +9.5%11.0%9.1 $14.74
1/31/20255,990,000 shares $83.68 million +1.0%N/A8 $13.97
1/15/20255,930,000 shares $59.72 million +9.8%N/A8.8 $10.07
12/31/20245,400,000 shares $59.62 million +4.3%N/A8.6 $11.04
12/15/20245,180,000 shares $59.62 million -0.6%N/A8.6 $11.51
11/30/20245,210,000 shares $71.32 million -1.5%N/A8.2 $13.69
11/15/20245,290,000 shares $64.06 million -2.6%N/A8.4 $12.11
10/31/20245,430,000 shares $88.62 million +8.8%N/A8.9 $16.32
10/15/20244,990,000 shares $83.33 million +3.1%N/A8.5 $16.70
9/30/20244,840,000 shares $78.41 million -0.8%N/A8.8 $16.20
9/15/20244,880,000 shares $85.35 million +2.3%N/A9 $17.49
8/31/20244,770,000 shares $75.80 million -1.0%N/A9.5 $15.89
8/15/20244,820,000 shares $65.55 million -4.4%N/A9.6 $13.60
7/31/20245,040,000 shares $62.60 million -4.0%N/A9.8 $12.42
7/15/20245,250,000 shares $63.37 million +10.5%9.7%9.8 $12.07
6/30/20244,750,000 shares $51.54 million +4.6%8.8%8.7 $10.85
6/15/20244,540,000 shares $51.44 million +2.0%8.4%8.3 $11.33
5/31/20244,450,000 shares $57.54 million -4.1%8.3%7.7 $12.93
5/15/20244,640,000 shares $61.43 million -2.9%8.6%7.4 $13.24
4/30/20244,780,000 shares $56.26 million +3.0%9.7%7.7 $11.77
4/15/20244,640,000 shares $55.17 million -0.2%9.6%8.1 $11.89
3/31/20244,650,000 shares $65.10 million -6.6%9.8%7.1 $14.00
3/15/20244,980,000 shares $69.22 million +0.4%10.5%7.7 $13.90
2/29/20244,960,000 shares $73.56 million +1.2%11.3%8.2 $14.83
2/15/20244,900,000 shares $67.47 million +2.9%11.1%8.1 $13.77
1/31/20244,760,000 shares $60.40 million +17.2%10.8%6.6 $12.69
1/15/20244,060,000 shares $42.83 million -7.3%9.2%5.4 $10.55
12/31/20234,380,000 shares $46.12 million -1.1%9.9%6.3 $10.53
12/15/20234,430,000 shares $43.86 million -9.0%10.0%6.5 $9.90
11/30/20234,870,000 shares $46.12 million -25.4%11.0%7.3 $9.47
11/15/20236,530,000 shares $58.18 million +60.8%14.8%10.2 $8.91
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
10/31/20234,060,000 shares $30.86 million +4.4%9.2%7.1 $7.60
10/15/20233,890,000 shares $31.66 million +1.3%8.8%6.5 $8.14
9/30/20233,840,000 shares $35.10 million +7.9%9.1%7.1 $9.14
9/15/20233,560,000 shares $33.61 million +5.3%8.4%6.2 $9.44
8/31/20233,380,000 shares $33.43 million -0.6%8.0%5.1 $9.89
8/15/20233,400,000 shares $34.68 million -21.7%8.1%5 $10.20
7/31/20234,340,000 shares $43.49 million -1.6%10.1%6.2 $10.02
7/15/20234,410,000 shares $32.63 million +24.6%10.3%7.8 $7.40
6/30/20233,540,000 shares $25.74 million +17.6%8.3%6.1 $7.27
6/15/20233,010,000 shares $23.15 million +7.1%7.1%5.6 $7.69
5/31/20232,810,000 shares $25.43 million -0.4%6.6%5.6 $9.05
5/15/20232,820,000 shares $29.10 million +2.2%6.6%6.4 $10.32
4/30/20232,760,000 shares $24.12 million +9.5%6.6%5.4 $8.74
4/15/20232,520,000 shares $21.14 million +4.1%6.0%4.8 $8.39
3/31/20232,420,000 shares $20.47 million +10.5%5.8%4.6 $8.46
3/15/20232,190,000 shares $18.75 million -0.9%5.2%4.1 $8.56
2/28/20232,210,000 shares $20.04 million -6.4%5.4%4.2 $9.07
2/15/20232,360,000 shares $22.11 million +6.3%5.8%4.5 $9.37
1/31/20232,220,000 shares $23.07 million -14.3%6.1%4.6 $10.39
1/15/20232,590,000 shares $22.40 million +0.4%7.0%6.2 $8.65
12/30/20222,580,000 shares $19.38 million +33.7%7.0%6.7 $7.51
12/15/20221,930,000 shares $13.55 million -15.4%5.2%4.8 $7.02
11/30/20222,280,000 shares $16.51 million -2.6%6.2%5.7 $7.24
11/15/20222,340,000 shares $17.64 million -8.2%6.3%5.7 $7.54
10/31/20222,550,000 shares $21.83 million -5.2%6.9%5.7 $8.56
10/15/20222,690,000 shares $22.41 million +24.0%7.3%5.2 $8.33
9/30/20222,170,000 shares $17.47 million +11.3%5.9%4.1 $8.05
9/15/20221,950,000 shares $19.81 million -5.3%5.3%3.9 $10.16
8/31/20222,060,000 shares $19.80 million -3.7%5.7%3.9 $9.61
8/15/20222,140,000 shares $20.24 million +6.5%6.0%4 $9.46
7/31/20222,010,000 shares $24.78 million -7.4%5.6%3.4 $12.33
7/15/20222,170,000 shares $27.80 million -8.1%6.1%4.3 $12.81
6/30/20222,360,000 shares $27.38 million -8.2%6.6%4.7 $11.60
6/15/20222,570,000 shares $30.40 million -13.2%7.2%5.1 $11.83
5/31/20222,960,000 shares $38.18 million -2.6%8.3%5.8 $12.90
5/15/20223,040,000 shares $40.07 million +22.1%8.5%6.2 $13.18
4/30/20222,490,000 shares $27.86 million +9.2%7.0%5.5 $11.19
4/15/20222,280,000 shares $25.72 million -1.7%6.4%4.7 $11.28
3/31/20222,320,000 shares $26.03 million -7.2%6.6%4.7 $11.22
3/15/20222,500,000 shares $24.88 million +4.2%7.1%5 $9.95
2/28/20222,400,000 shares $21.96 million -4.4%6.8%5 $9.15
2/15/20222,510,000 shares $22.82 million -12.5%7.1%5.1 $9.09
1/31/20222,870,000 shares $21.30 million +6.7%8.2%5.9 $7.42
1/15/20222,690,000 shares $15.47 million +3.5%N/A0 $5.75
12/31/20212,600,000 shares $16.93 million +12.1%7.2%6 $6.51
12/15/20212,320,000 shares $13.48 million +7.9%6.4%4.8 $5.81
11/30/20212,150,000 shares $11.91 million +1.9%6.0%4.3 $5.54
11/15/20212,110,000 shares $14.98 million -4.5%5.9%4.1 $7.10
10/29/20212,210,000 shares $17.28 million -11.6%6.1%4.2 $7.82
10/15/20212,500,000 shares $19.18 million +4.6%7.1%4.7 $7.67
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
9/30/20212,390,000 shares $18.21 million -1.2%6.8%4.6 $7.62
9/15/20212,420,000 shares $19.60 million -3.6%6.8%4.6 $8.10
8/31/20212,510,000 shares $26.61 million -21.6%7.7%4.7 $10.60
8/13/20213,200,000 shares $33.92 million -10.4%9.7%6.3 $10.60
7/30/20213,570,000 shares $38.63 million +1.7%10.7%6.4 $10.82
7/15/20213,510,000 shares $40.61 million +9.7%10.6%5.4 $11.57
6/30/20213,200,000 shares $40.48 million +13.1%9.7%4.1 $12.65
6/15/20212,830,000 shares $33.56 million -5.0%8.6%3.1 $11.86
5/28/20212,980,000 shares $32.24 million -19.9%9.0%3.1 $10.82
5/14/20213,720,000 shares $32.22 million +10.7%N/A3.4 $8.66
4/30/20213,360,000 shares $30.68 million -8.7%N/A2 $9.13
4/15/20213,680,000 shares $43.13 million +22.7%17.4%2.2 $11.72
3/31/20213,000,000 shares $35.25 million +2.0%15.5%1.9 $11.75
3/15/20212,940,000 shares $39.25 million -8.1%16.7%2 $13.35
2/26/20213,200,000 shares $36.80 million -3.3%22.4%2.1 $11.50
2/12/20213,310,000 shares $23.30 million -9.6%15.6%2.3 $7.04
1/29/20213,660,000 shares $23.94 million -11.4%17.2%4.6 $6.54
1/15/20214,130,000 shares $23.33 million +5.9%18.9%5.4 $5.65
12/31/20203,900,000 shares $13.26 million +5.1%17.8%6.1 $3.40
12/15/20203,710,000 shares $14.36 million -6.8%16.9%6.3 $3.87
11/30/20203,980,000 shares $15.24 million -0.5%18.2%9 $3.83
11/15/20204,000,000 shares $14.08 million +6.7%18.3%8.7 $3.52
10/30/20203,750,000 shares $10.95 million +8.7%17.1%8.9 $2.92
10/15/20203,450,000 shares $14.84 million +0.6%15.7%7.7 $4.30
9/30/20203,430,000 shares $13.41 million -15.3%15.6%0 $3.91
9/15/20204,050,000 shares $14.82 million -6.9%18.5%5.6 $3.66
8/31/20204,350,000 shares $16.79 million -6.7%19.8%5.8 $3.86
8/14/20204,660,000 shares $17.34 million -7.4%21.2%5 $3.72
7/31/20205,030,000 shares $16.40 million -4.2%22.9%4.4 $3.26

EOLS Short Interest - Frequently Asked Questions

What is Evolus' current short interest?

Short interest is the volume of Evolus shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 12,000,000 shares of EOLS short. 19.78% of Evolus' shares are currently sold short. Learn More on Evolus' current short interest.

What is a good short interest ratio for Evolus?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EOLS shares currently have a short interest ratio of 11.0. Learn More on Evolus's short interest ratio.

Which institutional investors are shorting Evolus?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolus: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Evolus?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.78% of Evolus' floating shares are currently sold short.

Is Evolus' short interest increasing or decreasing?

Evolus saw a increase in short interest in June. As of June 30th, there was short interest totaling 12,000,000 shares, an increase of 13.1% from the previous total of 10,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Evolus' short interest compare to its competitors?

19.78% of Evolus' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evolus: ImmunityBio, Inc. (37.57%), Bausch Health Cos Inc. (2.86%), Agios Pharmaceuticals, Inc. (6.83%), Centessa Pharmaceuticals PLC Sponsored ADR (4.53%), Beam Therapeutics Inc. (24.82%), Twist Bioscience Corporation (0.05%), Kiniksa Pharmaceuticals International, plc (6.10%), Disc Medicine, Inc. (14.58%), Galapagos NV (2.97%), CG Oncology, Inc. (25.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Evolus stock?

Short selling EOLS is an investing strategy that aims to generate trading profit from Evolus as its price is falling. EOLS shares are trading down $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Evolus?

A short squeeze for Evolus occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EOLS, which in turn drives the price of the stock up even further.

How often is Evolus' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EOLS, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:EOLS) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners